CalPERS approves 7.2% increase in HMO rates as drug costs climb

Jun 18, 2015

CalPERS said it spent nearly $40 million for Sovaldi on plans run by Blue Shield of California, Kaiser Permanente and CVS Health. Read More

Skyrocketing drug prices leave cures out of reach for some patients

Jun 16, 2015

Sophisticated drugs are opening the door, scientists say, to an era of "precision medicine." They're also ushering in an age of astronomical prices. Read More

ICYMI: National Journal article features CSRxP’s White Paper

Apr 21, 2015

This morning, the National Journal published an article regarding an increase in public concern over the high cost of prescription drugs. The article references CSRxP’s white paper, “Specialty Drug Hyperinflation: The Risk to Patients and the Health Care System.” Read More

Big Pharma Plays Hide-the-Ball With Data

Nov 17, 2014

The revelation of hidden data bolstered a growing movement against what’s referred to within the research community as “publication bias,” in which scientists squirrel away mostly negative or inconclusive findings and broadcast only their positive ones. Read More